Form 4 for APRE Aprea Therapeutics, Inc.
Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-25 · accession 0001104659-21-110595 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-27 | 2021-08-25 | APRE | Attar Eyal C. | SVP, Chief Medical Off | F - Tax | $3.98 | -9,032 | 99.0K | -8% | -$35.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-25 | F | D | 9,032 | $3.98 | 98,968 | D | — | — | (F1) Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 25,000 restricted stock units |